Capital Analysts »

Achieve Life Sciences shares owned by Capital Analysts

Quarter-by-quarter ownership of Achieve Life Sciences (ACHV) shares owned by Capital Analysts from 13F filings

Historical chart of Capital Analysts investment in Achieve Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Achieve Life Sciences held by Capital Analysts consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achieve Life Sciences by Capital Analysts

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.0k 510 3.92

More positions owned by Capital Analysts

Spdr Series Trust Portfolio S&p500 (SPLG)
Ishares Tr Core S&p500 Etf (IVV)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Flexshares Tr Iboxx 5yr Trgt (TDTF)
Fidelity Covington Trust Enhanced Mid (FMDE)
Microsoft Corporation (MSFT)
Spdr Series Trust Portfolio Intrmd (SPIB)
Spdr Series Trust Portfli High Yld (SPHY)
Franklin Templeton Etf Tr Intl Cor Div Til (DIVI)
Apple (AAPL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Bd Index Fds Short Trm Bond (BSV)

View all positions for Capital Analysts

Top funds holding Achieve Life Sciences

Propel Bio Management
Vanguard Group
Simplify Asset Management
Marshall Wace
Nantahala Capital Management
Geode Capital Management
Pathstone Holdings
Susquehanna International
Raymond James Financial
Clearline Capital
Two Sigma Investments
BlackRock
Squarepoint Ops
LPL Financial
Renaissance Technologies

View all funds holding Achieve Life Sciences